BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7610936)

  • 21. Biochemical assessment of Paget's disease of bone.
    Shankar S; Hosking DJ
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P22-7. PubMed ID: 17229003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diagnostic validity of urinary free pyridinolines to identify women at risk of osteoporosis.
    Fledelius C; Riis BJ; Overgaard K; Christiansen C
    Calcif Tissue Int; 1994 May; 54(5):381-4. PubMed ID: 8062154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen.
    Bonde M; Garnero P; Fledelius C; Qvist P; Delmas PD; Christiansen C
    J Bone Miner Res; 1997 Jul; 12(7):1028-34. PubMed ID: 9200001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Urinary excretion of free and total deoxypyridinoline during secondary hyperparathyroidism in the elderly. Comparison of chromatographic (HPLC) and immunoenzymatic (Pyrilinks-D) methods].
    Meddah B; Brazier M; Kamel S; Maamer M; Samson L; Desmet G; Sebert JL
    Ann Biol Clin (Paris); 1996; 54(10-11):353-8. PubMed ID: 9092303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analytical and clinical evaluation of the Bio-Rad HPLC kit for measurement of type I collagen cross links.
    Srivastava AK; Libanati C; Oberrauch W; Leenings J; Greenwald M; Baylink DJ
    J Bone Miner Metab; 2003; 21(3):134-44. PubMed ID: 12720047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease.
    Meier C; Meinhardt U; Greenfield JR; De Winter J; Nguyen TV; Dunstan CR; Seibel MJ
    Clin Lab; 2006; 52(1-2):1-10. PubMed ID: 16506358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
    Alvarez L; Peris P; Guañabens N; Vidal S; Quintó L; Monegal A; Pons F; Ballesta AM; Muñoz-Gómez J
    Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical usefulness of measurements of urinary deoxypyridinoline (DPD) in patients with postmenopausal osteoporosis receiving intermittent cyclical etidronate: advantage of free form of DPD over total DPD in predicting treatment efficacy.
    Kitatani K; Nakatsuka K; Naka H; Miki T; Morii H; Nishizawa Y
    J Bone Miner Metab; 2003; 21(4):217-24. PubMed ID: 12811626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated and manual assays for urinary crosslinks of collagen: which assay to use?
    Seibel MJ; Woitge HW; Farahmand I; Oberwittler H; Ziegler R
    Exp Clin Endocrinol Diabetes; 1998; 106(2):143-8. PubMed ID: 9628247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different responses of free and peptide-bound cross-links to vitamin D and calcium supplementation in elderly women with vitamin D insufficiency.
    Kamel S; Brazier M; Rogez JC; Vincent O; Maamer M; Desmet G; Sebert JL
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3717-21. PubMed ID: 8855828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous free and glycosylated pyridinium crosslink determination in urine: validation of an HPLC-fluorescence method using a deoxypyridinoline homologue as internal standard.
    Monticelli E; Aman CS; Costa ML; Rota P; Bogdan D; Allevi P; Cighetti G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(26):2764-71. PubMed ID: 21855424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Markers of bone resorption--measurement in serum, plasma or urine?
    Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H
    Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.
    Garnero P; Fledelius C; Gineyts E; Serre CM; Vignot E; Delmas PD
    J Bone Miner Res; 1997 Sep; 12(9):1407-15. PubMed ID: 9286756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption.
    Papapoulos SE; Frölich M
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3993-7. PubMed ID: 8923849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Monitoring markers of bone turnover in multiple myeloma].
    Spicka I; Spacek P; Hulejová H; Procházka B; Cieslar P; Chrz M; Válková V; Klener P
    Vnitr Lek; 1999 Aug; 45(8):463-7. PubMed ID: 11045145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis.
    Delmas PD; Schlemmer A; Gineyts E; Riis B; Christiansen C
    J Bone Miner Res; 1991 Jun; 6(6):639-44. PubMed ID: 1887826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of surgical menopause and Paget's disease of bone on the isomerization of type I collagen carboxyterminal telopeptide: evolution after antiresorptive therapy.
    Peris P; Alvarez L; Monegal A; Guañabens N; Durán M; Echevarría M; Ros I; Ballesta AM; Muñoz-Gómez J
    J Bone Miner Metab; 2002; 20(2):116-20. PubMed ID: 11862534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodium.
    Price RI; Gutteridge DH; Stuckey BG; Kent GN; Retallack RW; Prince RL; Bhagat CI; Johnston CA; Nicholson GC; Stewart GO
    J Bone Miner Res; 1993 Feb; 8(2):209-17. PubMed ID: 8442439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of immuno- and HPLC-assays for the measurement of urinary collagen cross-links.
    Calabresi E; Lasagni L; Franceschelli F; de Leonardis V; Becorpi A; Serio M; Brandi ML
    J Endocrinol Invest; 1994 Sep; 17(8):625-9. PubMed ID: 7868800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of pyridinium crosslinks in postmenopausal women and in Paget's disease of bone.
    Sinigaglia L; Varenna M; Binelli L; Beltrametti P; Zucchi F; Arrigoni M; Frignani S; Abbiati G
    Calcif Tissue Int; 1997 Oct; 61(4):279-84. PubMed ID: 9312197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.